New Device May Ease Diabetic Care

A new insulin device created for diabetics by MannKind Corp has proven to be just as effective or more effective than oral or injected treatments. The new product is called Afrezza and is a small inhaler that releases insulin in powder form to individuals with Type 1 and Type 2 diabetes. According to Transparency Market Research, diabetes is a growing disease; researchers estimate that a half billion worldwide cases will be diagnosed by the year 2030. The creators of Afrezza hope that the device will improve the quality of life for diabetics around the world. More here

Leave a Reply

Your email address will not be published. Required fields are marked *